Clinical characteristics of patients in the fluticasone and placebo groups at baseline
Fluticasone(n = 43, 23F) | Placebo(n = 43, 34F) | |
---|---|---|
Data shown are mean (SD). | ||
*No significant difference between fluticasone and placebo groups (p>0.05). | ||
Age (years) | 57.7 (14.4) | 59.2 (14.2) |
Age at onset of symptoms (years) | 41.8 (18.8) | 40.8 (18.5) |
Smoking history | ||
Never | 33 | 36 |
Ex | 8 | 7 |
Current | 2 | 0 |
Past medical history | ||
Nil else | 26 | 25 |
Hypertension | 5 | 4 |
Hypothyroidism | 0 | 2 |
Pulmonary TB | 3 | 0 |
Ischaemic heart disease | 2 | 4 |
Peptic ulcer disease | 2 | 2 |
Others | 8 | 7 |
Current medications | ||
None | 17 | 11 |
Inhaled bronchodilators | 11 | 19 |
Antihypertensives | 5 | 5 |
Theophylline or oral β2 agonist | 7 | 7 |
Others | 12 | 8 |
Sputum pathogen | ||
Commensals | 25 | 27 |
P aeruginosa | 12 | 11 |
H influenzae | 6 | 5 |
No. of bronchiectatic lung segments | 3.0 (1.6) | 2.8 (1.6) |